Interferon-beta antibodies: implications for the treatment of MS
Lancet Neurol
.
2003 Sep;2(9):528.
doi: 10.1016/s1474-4422(03)00499-x.
Authors
Jerry S Wolinsky
,
Klaus V Toyka
,
Ludwig Kappos
,
Sidney E Grossberg
PMID:
12941572
DOI:
10.1016/s1474-4422(03)00499-x
No abstract available
Publication types
Review
MeSH terms
Antibodies / immunology
Humans
Interferon-beta / immunology*
Interferon-beta / therapeutic use*
Multiple Sclerosis / drug therapy*
Substances
Antibodies
Interferon-beta